Bixiye
QP63-19 When the Authorization Tool is Utilized on the Availity Portal
Taariikhda wax ku ool ah ee barnaamijka: Jun 26, 2019
Natiijooyinka Raadinta
Soo bandhiga 2821 - 2830 ee natiijooyinka 4130
Bixiye
QP58-19 Pharmacy Benefit Exclusion for Zolgensma (onasemnogene abeparvovec-xioi) Injection
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP56-19 Pharmacy Benefit Update – New Drug-Related Step Therapy Criteria: Topical Corticosteroids
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP48-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Somatostatin Analogs
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP47-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP57-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization Criteria: tafamidis
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP49-19 Pharmacy Benefit Exclusion for Proventil (albuterol sulfate) HFA and Proventil (albuterol sulfate) HFA Authorized Generic (AG)
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP54-19 Pharmacy Benefit Update – New Drug-Related Utilization Management Program: Opioid Immediate Release (IR) New to Therapy (NTT) Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP52-19 Pharmacy Benefit Exclusion for Cimzia, Elzonris, Gamifant, Kalbitor, Khapzory, leucovorin calcium, Nuzyra and Panzyga
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP53-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Neurotrophic Keratitis
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019